Pfizer Booster Dose Authorization From US FDA Has Age Caveat: At-Risk Populations 18 And Up

 
• By M. Nielsen Hobbs
  
Pfizer is hoping its booster shot will have a star turn in the pandemic response. • Source: Nielsen Hobbs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet